FIELD: medicine, oncology. SUBSTANCE: the present innovation deals with treating non-Hodgkin's lymphomas and granulomatosis. On the 1st and 8th d of therapy it is suggested to carry out plasmapheresis, sample autoplasma at the quantity of 200-250 ml, conduct chemotherapy course: vincristine 1 mg, doxorubicin 40-50 mg, cyclophosphan 600-800 mg; cytostatics should be mixed with autoplasma, incubated at 37 C for 1 h and reinfused for a patient. Therapy should be performed at the background of prednisolone application at the dosage of 40 mg/d from the 1st till 14th d either inside or intramuscularly. EFFECT: higher efficiency of therapy. 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING THE CASES OF MAMMALIAN GLAND CARCINOMA | 2001 |
|
RU2203687C2 |
METHOD FOR TREATING MALIGNANT TUMORS | 2001 |
|
RU2210390C2 |
METHOD FOR TREATING THE CASES OF NON-OPERABLE CANCER METASTASIZING INTO LYMPH NODES | 2002 |
|
RU2218186C2 |
METHOD OF NEOADJUVANT CHEMOTHERAPY OF MAMMARY GLAND CANCER | 2007 |
|
RU2338545C1 |
METHOD FOR TREATING HODGKIN LYMPHOMA CASES | 2004 |
|
RU2280452C2 |
METHOD OF REDUCTION OF TOXICITY OF CHEMOTHERAPY OF MALIGNANT TUMORS | 2001 |
|
RU2201260C1 |
METHOD FOR TREATING TUMOR PLEURITIS | 2002 |
|
RU2225228C2 |
ANTIBIOTIC THERAPY METHOD | 2001 |
|
RU2195294C1 |
METHOD OF TREATMENT OF PATIENTS WITH BREAST CANCER | 1998 |
|
RU2145239C1 |
METHOD FOR TREATMENT OF ABDOMINAL CAVITY PRIMARY AND METASTATIC TUMORS | 2003 |
|
RU2272655C2 |
Authors
Dates
2003-05-10—Published
2001-08-01—Filed